122 related articles for article (PubMed ID: 17322111)
21. Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction.
Kim V; Oros M; Durra H; Kelsen S; Aksoy M; Cornwell WD; Rogers TJ; Criner GJ
PLoS One; 2015; 10(2):e0116108. PubMed ID: 25646735
[TBL] [Abstract][Full Text] [Related]
22. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction.
Innes AL; Woodruff PG; Ferrando RE; Donnelly S; Dolganov GM; Lazarus SC; Fahy JV
Chest; 2006 Oct; 130(4):1102-8. PubMed ID: 17035444
[TBL] [Abstract][Full Text] [Related]
23. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.
Caramori G; Di Gregorio C; Carlstedt I; Casolari P; Guzzinati I; Adcock IM; Barnes PJ; Ciaccia A; Cavallesco G; Chung KF; Papi A
Histopathology; 2004 Nov; 45(5):477-84. PubMed ID: 15500651
[TBL] [Abstract][Full Text] [Related]
24. [An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema].
Zhong XN; Bai J; Shi HZ; Wu C; Liang GR; Feng ZB
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Dec; 26(12):750-5. PubMed ID: 14720429
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD.
Baraldo S; Bazzan E; Turato G; Calabrese F; Beghé B; Papi A; Maestrelli P; Fabbri LM; Zuin R; Saetta M
Thorax; 2005 Dec; 60(12):998-1002. PubMed ID: 16227324
[TBL] [Abstract][Full Text] [Related]
26. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
Chu S; Zhong X; Zhang J; Lao Q; He Z; Bai J
Int Immunopharmacol; 2011 Nov; 11(11):1780-8. PubMed ID: 21791252
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease.
Sapey E; Wood AM; Ahmad A; Stockley RA
Am J Respir Crit Care Med; 2010 Jul; 182(2):192-9. PubMed ID: 20299531
[TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI).
Maestrelli P; Occari P; Turato G; Papiris SA; Di Stefano A; Mapp CE; Milani GF; Fabbri LM; Saetta M
Clin Exp Allergy; 1997 Nov; 27(11):1292-8. PubMed ID: 9420133
[TBL] [Abstract][Full Text] [Related]
29. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
[TBL] [Abstract][Full Text] [Related]
30. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.
Andersson CK; Mori M; Bjermer L; Löfdahl CG; Erjefält JS
Am J Respir Crit Care Med; 2010 Feb; 181(3):206-17. PubMed ID: 19926870
[TBL] [Abstract][Full Text] [Related]
31. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.
Calabrese F; Baraldo S; Bazzan E; Lunardi F; Rea F; Maestrelli P; Turato G; Lokar-Oliani K; Papi A; Zuin R; Sfriso P; Balestro E; Dinarello CA; Saetta M
Am J Respir Crit Care Med; 2008 Nov; 178(9):894-901. PubMed ID: 18703789
[TBL] [Abstract][Full Text] [Related]
32. Severity of airflow limitation is associated with severity of airway inflammation in smokers.
Di Stefano A; Capelli A; Lusuardi M; Balbo P; Vecchio C; Maestrelli P; Mapp CE; Fabbri LM; Donner CF; Saetta M
Am J Respir Crit Care Med; 1998 Oct; 158(4):1277-85. PubMed ID: 9769292
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
34. Cold temperature induces mucin hypersecretion from normal human bronchial epithelial cells in vitro through a transient receptor potential melastatin 8 (TRPM8)-mediated mechanism.
Li M; Li Q; Yang G; Kolosov VP; Perelman JM; Zhou XD
J Allergy Clin Immunol; 2011 Sep; 128(3):626-34.e1-5. PubMed ID: 21762971
[TBL] [Abstract][Full Text] [Related]
35. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB.
Ou XM; Feng YL; Wen FQ; Wang K; Yang J; Deng ZP; Liu DS; Li YP
Respirology; 2008 Jan; 13(1):63-72. PubMed ID: 18197913
[TBL] [Abstract][Full Text] [Related]
36. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
Jeffery PK
Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
[TBL] [Abstract][Full Text] [Related]
37. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
38. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma.
Shimura S; Andoh Y; Haraguchi M; Shirato K
Eur Respir J; 1996 Jul; 9(7):1395-401. PubMed ID: 8836649
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis.
Springer J; Groneberg DA; Pregla R; Fischer A
Regul Pept; 2005 Jan; 124(1-3):195-201. PubMed ID: 15544859
[TBL] [Abstract][Full Text] [Related]
40. Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study.
Rogers AV; Adelroth E; Hattotuwa K; Dewar A; Jeffery PK
Thorax; 2008 Feb; 63(2):108-14. PubMed ID: 17875567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
